Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05352672 |
|---|---|
| Brief Title: | Clinical Study of Fianlimab in Combination With Cemiplimab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma |
| First Submitted : | April 6, 2022 |
| First Submitted that Met QC Criteria : | April 25, 2022 |
| First Posted : | April 29, 2022 |
| Last Update Submitted that Met QC Criteria : | February 21, 2024 |
| Last Update Posted : | February 22, 2024 |